Free Shipping for any 2 packs purchased

Regulatory proof

CE marked and registered in the EU as a Class I medical device under EU MDR (EU) 2017/745, with an appointed EU Authorised Representative and an active EUDAMED registration; FDA registered as a Class I medical device establishment in the United States; ISO 13485 certified; skin biocompatibility assessed to the ISO 10993 series, including cytotoxicity, sensitisation and irritation testing.

Research collaborations

Yale School of Public Health’s GROW study is examining gestational diabetes among American Samoan women, and Not Just a Patch is named as its adhesive-patch partner – a small part of a study built to produce real answers.

Not Just a Patch is a named partner of the TIMES study, Diabetes Center Berne’s international research effort tracking how insulin sensitivity shifts across the menstrual cycle in 350 women with type 1 diabetes across five countries. It’s a relationship that runs deeper as our founder Pete Lomas has engaged directly with DCB CEO Derek Brandt on the center’s broader mission to fund and coach innovative diabetes technology.

 

Healthcare Professional (HCP) Grant Programme

Our Healthcare Professional (HCP) Grant Programme supports diabetes educators and recognises their contribution to the diabetes community. The programme provides AUD 1,500 to one recipient in each of three regional categories: Australia and New Zealand, Europe and North America.

2024 winners
We announced our 2024 winners in February 2024, following applications collected during 2023.

Australia/New Zealand: Beck Newton
Europe: Nadia Roberts, a diabetes specialist nurse in London.
North America: Anna Reinwand

For media enquiries about the programme, please contact press@notjustapatch.com.

 

Verified fact sheet

Founded by Pete Lomas in Potts Point, Sydney: the idea in January 2019, the first sale in July 2019. Pete was diagnosed with type 1 diabetes at thirty and trains for the Bondi to Bronte ocean swim. Retail presence at CVS, Walgreens and Chemist Warehouse; trusted by people with diabetes across 65+ countries. Patches support sensors worn 10 to 15 days and are compatible with Dexcom, Libre, Medtronic, Omnipod and MiaoMiao, with medical-grade adhesive designed to minimise skin reactions. Research collaborations, described as collaborations and never endorsements: the Yale GROW study, where Yale’s own news coverage names Not Just a Patch directly as the study’s adhesive-patch partner, and the Diabetes Center Bern TIMES study, where the brand appears as a named partner, logo included, on the study page. The Global HPC/CDE/CDCES Grant Funding Program has run since 2023, awarding AUD 1,500 to one credentialed diabetes educator in each of three regions per cycle; past winners include Anna Reinwand (US), Beck Newton (Australia) and Nadia Roberts (UK). Contracting entity: NJAP1922 Limited, Ireland.

Press assets

Not Just a Patch provides imagery and brand assets for use by journalists and media in online and print outlets (newspapers, magazines, newsletters and websites). By downloading the photos, you agree to the terms of use below. All assets are approved for editorial use.

You can download the brand logo files, the founder photo and the product photography with our patches on real and diverse skin, by clicking on Not Just a Patch Media Kit. Format: PNG files. The download will start automatically.

Brand assets terms of use:

You are welcome to use the following pictures / logos for journalistic endeavors.
Please note the following:

  • Not Just a Patch is the sole owner of the rights to the images provided. These graphics are proprietary and protected under intellectual property laws.
  • The images are only available for journalistic and editorial use in print and online media. Commercial use is excluded.
  • The files may not be used in any way that distorts or changes their meaning.
  • The files may not be used in an unrelated context or environment.
  • Please indicate “Not Just a Patch” as the source for all images.

 

Boilerplate

Not Just a Patch is the first patch brand to be FDA registered and CE marked under EU MDR as a Class I medical device. Founded in Sydney in 2019 by Pete Lomas, after his own sensor kept lifting during ocean swims, the company makes adhesive patches that protect CGM sensors through sport, water and daily life, compatible with Dexcom, Libre, Medtronic, Omnipod and MiaoMiao. Its patches are trusted by people with diabetes across 18+ countries; the company is ISO 13485 certified, with skin biocompatibility assessed to the ISO 10993 series, research collaborations at Yale and the Diabetes Center Bern, and a grants program for diabetes educators running since 2023.

Founder bio

Pete Lomas founded Not Just a Patch after experiencing a practical problem firsthand at his kitchen table in Potts Point, Sydney: his continuous glucose sensor repeatedly lifted during ocean swims.

Diagnosed with type 1 diabetes at thirty, Pete began working on a way to protect his sensor during water exposure, exercise, and daily wear while training for the Bondi to Bronte ocean swim. The idea took shape in January 2019, and the company made its first sale in July of that year.

Since then, Not Just a Patch has grown from a bootstrapped Sydney apartment project into a brand with commercial reach in more than 65 countries and availability through pharmacy retailers including CVS, Walgreens and Chemist Warehouse. Pete and the company were also featured in Amazon Australia’s 2026 small-business campaign.

Pete leads the business from the dual perspective of founder and person living with type 1 diabetes. That position shapes how he approaches product decisions, community needs, evidence and trust. He declares his commercial interest whenever he comments publicly and is clear about the product’s role: the patch does not treat or manage diabetes; it is designed to help protect the sensor worn by the person using it.

Media contact

For media inquiries, please contact:

Claudia Szanto

press@notjustapatch.com

 


Media Highlights

INTERVIEW – Authority Magazine | Pete Lomas on making difficult leadership decisions | September 24, 2026.